Kyouko Kishima

发表

Efficacy of modified bevacizumab-XELOX therapy in Japanese patients with stage IV recurrent or non-resectable colorectal cancer.

E. Nomura, H. Makuuchi, M. Mukai, 2021, Journal of Gastrointestinal Oncology.